| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |